Hernandez Magali, Pochon Cécile, Chastagner Pascal, Droz Dominique
Pediatric Dentistry Department, Children Hospital, CHRU Nancy, France; Pediatric Dental Department, Faculty of Dentistry, Nancy, France.
Hematology, Oncology Department, Children Hospital, CHRU Nancy, France.
Int J Clin Pediatr Dent. 2019 May-Jun;12(3):243-246. doi: 10.5005/jp-journals-10005-1614.
Several studies showed that cancer therapies during tooth development are associated with dental abnormalities, including enamel defects, arrested tooth development, microdontic teeth, and agenesis.
We describe the case of a nine-year-old boy treated for acute myeloid leukemia at 15 months of age, who presents several dental abnormalities resulting from anticancer treatment.
The patient was included and treated according to the ELAM 02 French protocol. Six years after allogenic hematopoietic stem cell transplantation, the intraoral and radiographic examination highlighted the agenesis of the second permanent molars and three of the four second premolars, microdontia of the first premolars, root stunting of the central incisors and first premolars, rootlessness of the first permanent molars, and enamel defects localized at the permanent incisors and canines. As a first step to reduce enamel defects, restorations with resin composite (Tetric EvoCeram® A2, Ivoclar Vivadent) were performed under a dental dam. Orthodontic treatment was contraindicated due to arrested tooth development, short roots, and a risk of resorption is considered too important.
The young age at diagnosis (<5 years of age) and intensive chemotherapy (especially myeloablative conditioning with high doses of cyclophosphamide and Busulfan) could explain the severity of the dental abnormalities. This case illustrates the importance of systematically scheduling a dental follow-up in parallel with the onco-hematologic follow-up allowing the clinicians to prevent, detect, and propose early intervention for dental late effects.
Hernandez M, Pochon C, . Long-term Adverse Effects of Acute Myeloid Leukemia Treatment on Odontogenesis in a Child. Int J Clin Pediatr Dent 2019;12(3):243-246.
多项研究表明,牙齿发育期间接受癌症治疗与牙齿异常有关,包括牙釉质缺陷、牙齿发育停滞、过小牙和牙齿缺失。
我们描述了一名9岁男孩的病例,该男孩在15个月大时接受了急性髓系白血病治疗,目前存在抗癌治疗导致的多种牙齿异常。
该患者按照法国ELAM 02方案纳入并接受治疗。异基因造血干细胞移植6年后,口腔内和影像学检查发现第二恒磨牙和四颗第二前磨牙中的三颗缺失,第一前磨牙过小,中切牙和第一前磨牙牙根发育不良,第一恒磨牙无根,以及恒切牙和尖牙存在牙釉质缺陷。作为减少牙釉质缺陷的第一步,在橡皮障下用树脂复合材料(Tetric EvoCeram® A2,义获嘉伟瓦登特公司)进行了修复。由于牙齿发育停滞、牙根短,且认为吸收风险过高,正畸治疗为禁忌。
诊断时年龄较小(<5岁)和强化化疗(尤其是大剂量环磷酰胺和白消安的清髓预处理)可以解释牙齿异常的严重程度。该病例说明了在肿瘤血液学随访的同时系统安排牙科随访的重要性,以便临床医生预防、检测并对牙齿远期效应提出早期干预措施。
埃尔南德斯M,波雄C, 。儿童急性髓系白血病治疗对牙胚发生的长期不良影响。《国际临床儿科牙科学杂志》2019年;12(3):243 - 246。